Medi-MIBI (Tc-mr-1)

DESCRIPTION

Active substance: Sestamibi [tetrakis (1 isocyanide-2-methoxy-2-methylpropyl-) copper(I)] tetrafluoroborate 0.5 mg.

Medi-MIBI is for diagnostic use only.

After radiolabelling with sodium pertechnetate (99m-Tc) solution, the solution obtained is indicated for:

  • Myocardial perfusion scintigraphy

  • Assessment of global ventricular function

  • Scintimammography for the detection of suspected breast cancer

  • Localisation of hyperfunctioning parathyroid tissue

For more specific information, such as the dosage and pharmacological properties, please refer to the SmPC in your region:

Denmark (DK R 02236) - SmPC in DK

1 kit Medi-MIBI contains 6 vials